(E)-1-(4-chlorophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one | 286956-03-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (E)-1-(4-chlorophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one
• 英文别名: (2E)-1-(4-chlorophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one
• CAS: 286956-03-4
• 化学式: C₁₆H₁₃ClO₂
• 分子量: 272.731
• InChiKey: DUTKEQBTMRWRAC-DHZHZOJOSA-N

物化性质

• 熔点：
  76-78 °C(Solv: ethanol (64-17-5))
• 沸点：
  421.4±45.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (E)-1-(4-chlorophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one 在 溴 作用下， 以 氯仿 为溶剂， 反应 0.33h， 以97%的产率得到2,3-dibromo-1-(4-chlorophenyl)-3-(2-methoxyphenyl)propan-1-one
  参考文献：
  名称：

  [EN] SUBSTITUTED PURINONE COMPOUNDS
  [FR] COMPOSÉS DE PURINONE SUBSTITUÉS

  摘要：

  该发明涉及以下式(I)的化合物：(I)，如本文所述，包括这种化合物的药物制剂，以及在治疗由MDM2和/或MDM4活性介导的疾病或疾病中使用这种化合物的用途和方法，以及包含这种化合物的组合物。

  公开号：

  WO2014115077A1
• 作为产物：
  描述：

  对氯苯乙酮 、 邻甲氧基苯甲醛 在 silica gel supported sulfuric acid 作用下， 以 neat (no solvent) 为溶剂， 反应 1.5h， 以92%的产率得到(E)-1-(4-chlorophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one
  参考文献：
  名称：

  Evaluation of Silica-H2SO4 as an Efficient Heterogeneous Catalyst for the Synthesis of Chalcones

  摘要：

  我们报道了一种高效的二氧化硅-H2SO4介导的合成多种查尔酮的方法，该方法与碱催化的无溶剂条件以及酸或碱催化的回流条件相比，能够以非常好的产率获得目标化合物。

  DOI：

  10.3390/molecules180810081

文献信息

• SUBSTITUTED PURINONE COMPOUNDS
  申请人：FURET Pascal

  公开号：US20150353551A1

  公开（公告）日：2015-12-10

  The invention relates to compounds of formula (I): (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of as MDM2 and/or MDM4, and combinations comprising such compounds.

  本发明涉及式(I)的化合物：(I)如本文所述，包括这种化合物的药物制剂，以及在治疗由MDM2和/或MDM4活性介导的紊乱或疾病中使用这种化合物的用途和使用方法，以及包括这种化合物的组合物。
• Substituted purinone compounds
  申请人：Furet Pascal

  公开号：US09403827B2

  公开（公告）日：2016-08-02

  The invention relates to compounds of formula (I): (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of as MDM2 and/or MDM4, and combinations comprising such compounds.

  本发明涉及式(I)的化合物：(I)如此处所述，包括此类化合物的制药制剂，在治疗由MDM2和/或MDM4活性介导的疾病或疾患中使用此类化合物的用途和方法，以及包含此类化合物的组合物。
• Potent, orally absorbed glucagon receptor antagonists
  作者：Stephen E. de Laszlo、Candice Hacker、Bing Li、Dooseop Kim、Malcolm MacCoss、Nathan Mantlo、James V. Pivnichny、Larry Colwell、Gregory E. Koch、Margaret A. Cascieri、William K. Hagmann

  DOI：10.1016/s0960-894x(99)00081-5

  日期：1999.3

  The SAR of 2-pyridyl-3,5-diaryl pyrroles, ligands of the human glucagon receptor and inhibitors of p38 kinase, were investigated. This effort resulted in the identification of 2-(4-pyridyl)-5-(4-chlorophenyl)-3-(5-bromo-2-propyloxyphenyl)pyrrole 49 (L-168,049), a potent (Kb = 25 nM), selective antagonist of glucagon. (C) 1999 Elsevier Science Ltd. All rights reserved.
• The ortho effect: copper-catalyzed highly enantioselective 1,4-conjugate addition of diethylzinc to chalcones
  作者：Lan-Tao Liu、Min-Can Wang、Wen-Xian Zhao、Yan-Li Zhou、Xiao-Dan Wang

  DOI：10.1016/j.tetasy.2005.11.031

  日期：2006.1

  The copper-catalyzed enantioselective 1,4-conjugate addition of diethylzinc to chalcones was investigated in the presence of a catalytic amount of NP-ferrocenyl ligands with central and planar chirality under mild conditions (0 degrees C -> rt). It was found that chalcones with ortho-substituents (from ortho-substituted benzaldehydes and acetophenone/substituted acetophenones) led to a dramatic improvement in the enantio selectivities. The (R)- and (S)-antipodes of the addition reaction were obtained with up to 92% ee after this transformation. (c) 2006 Published by Elsevier Ltd.
• The pyrrole moiety as a template for COX-1/COX-2 inhibitors
  作者：Gerd Dannhardt、Werner Kiefer、Godehard Krämer、Sabine Maehrlein、Ulrike Nowe、Bernd Fiebich

  DOI：10.1016/s0223-5234(00)00150-1

  日期：2000.5

  Aroyl- and thiophene-substituted pyrrole derivatives have been synthesized as a new class of COX-1/COX-2 inhibitors. The inhibition of COX-1 was evaluated in a biological system using bovine PMNLs as the enzyme source, whereas LPS-stimulated human monocytes served as the enzyme source for inducible COX-2. The determination of the concentration of arachidonic acid metabolites was performed by HPLC for COX-1 and RIA for COX-2. Variation of the substitution pattern led to a series of active compounds which showed inhibition for COX-1 and COX-2. Structural requirements for the development of COX-1/COX-2 inhibitors are discussed, (C) 2000 Editions scientifiques et medicales Elsevier SAS.